The Briefing

Continuous newsroom coverage of clinically relevant evidence — newest first.

Earlier

24 stories
  1. Subthalamic Nucleus Predominantly Facilitates Action in Primate Models
    Progress in Neurobiology ·Animal Study · April 28, 2026

    Subthalamic Nucleus Predominantly Facilitates Action in Primate Models

    Electrophysiological data show 89 percent of task-related neurons in the subthalamic nucleus promote rather than inhibit motor choices.

  2. Cytotoxic T Cells Expand in Antibody-Mediated Kidney Transplant Rejection
    Kidney International ·Cohort Study · April 28, 2026

    Cytotoxic T Cells Expand in Antibody-Mediated Kidney Transplant Rejection

    Clonal T cell expansion occurs in antibody-mediated rejection even without histological evidence of T cell-mediated rejection.

  3. Lebrikizumab Maintains 48-Week Efficacy in Systemic-Naive and Experienced Atopic Dermatitis
    American journal of clinical dermatology ·Cohort Study · April 28, 2026

    Lebrikizumab Maintains 48-Week Efficacy in Systemic-Naive and Experienced Atopic Dermatitis

    A prospective study of 187 patients shows high response rates, though prior systemic therapy may limit clearance in head and neck lesions.

  4. Videolaryngoscopy Increases First-Attempt Success for Double-Lumen Tube Intubation
    British Journal of Anaesthesia ·Randomized Controlled Trial · April 28, 2026

    Videolaryngoscopy Increases First-Attempt Success for Double-Lumen Tube Intubation

    A multicenter trial of 916 patients shows digital visualization improves glottic view and reduces esophageal intubation rates.

  5. Online Therapist-Assisted Program Reduces Posttraumatic Stress in Injured Children
    JAMA Pediatrics ·Randomized Controlled Trial · April 28, 2026

    Online Therapist-Assisted Program Reduces Posttraumatic Stress in Injured Children

    A randomized trial shows a digital cognitive behavioral intervention lowers symptom scores for six months following pediatric hospitalization.

  6. Repeat OnabotulinumtoxinA for Masseter Prominence Does Not Alter Mandibular Bone
    Aesthetic Surgery Journal ·Randomized Controlled Trial · April 28, 2026

    Repeat OnabotulinumtoxinA for Masseter Prominence Does Not Alter Mandibular Bone

    A 12-month placebo-controlled trial using CT imaging shows no significant bone remodeling after masseter injections for facial contouring.

  7. Artificial Intelligence Matches Physician Committees in Adjudicating Cardiovascular Trial Endpoints
    Journal of the American College of Cardiology ·Diagnostic Accuracy Study · April 28, 2026

    Artificial Intelligence Matches Physician Committees in Adjudicating Cardiovascular Trial Endpoints

    An automated system shows high agreement with human experts in identifying major adverse cardiovascular events in a large clinical trial.

  8. Recurrent Renal Cell Carcinoma Downregulates MHC-I After Adjuvant Atezolizumab
    European Urology ·Cohort Study · April 28, 2026

    Recurrent Renal Cell Carcinoma Downregulates MHC-I After Adjuvant Atezolizumab

    Molecular analysis of IMmotion010 samples suggests a shift toward VEGF-targeted therapy when tumors recur after checkpoint inhibition.

  9. Trabeculectomy Slows Visual Field Loss Better Than Medication in Advanced Glaucoma
    Ophthalmology ·Randomized Controlled Trial · April 28, 2026

    Trabeculectomy Slows Visual Field Loss Better Than Medication in Advanced Glaucoma

    A five-year trial shows surgery preserves monocular vision but finds no significant difference in patient-reported quality of life.

  10. Serum Neurofilament Light Chain Tracks Acute Injury in Refractory Status Epilepticus
    JAMA Neurology ·Cohort Study · April 28, 2026

    Serum Neurofilament Light Chain Tracks Acute Injury in Refractory Status Epilepticus

    Elevated NfL levels distinguish cryptogenic NORSE from other seizure etiologies and correlate with poor functional outcomes at discharge.

  11. Heterogeneous Trial Endpoints Limit Evidence in Acute Kidney Injury
    Intensive care medicine ·Systematic Review · April 28, 2026

    Heterogeneous Trial Endpoints Limit Evidence in Acute Kidney Injury

    A review of 251 trials reveals inconsistent outcome definitions and measurements that hinder clinical application of renal research.

  12. Gastric Bypass Reversal Relieves Symptoms but Carries High Morbidity Risk
    Annals of Surgery ·Cohort Study · April 28, 2026

    Gastric Bypass Reversal Relieves Symptoms but Carries High Morbidity Risk

    A Swedish cohort study shows 86% symptom relief after reversal, though one in four patients faces early severe complications.

  13. Higher Daily Step Counts Linked to Reduced Bradykinesia and Increased Dyskinesia
    Neurorehabilitation and neural repair ·Cross-Sectional Study · April 28, 2026

    Higher Daily Step Counts Linked to Reduced Bradykinesia and Increased Dyskinesia

    Objective wearable data from 80 patients shows a correlation between physical activity and motor symptom trade-offs in Parkinson's disease.

  14. Menopause Linked to Significant Lung Function Decline Regardless of HIV Status
    CHEST Journal ·Cross-Sectional Study · April 28, 2026

    Menopause Linked to Significant Lung Function Decline Regardless of HIV Status

    Postmenopausal women aged 41 to 50 show a mean FEV1 reduction of 310 mL compared to premenopausal peers in a cross-sectional analysis.

  15. Schizophrenia Subtype Shows Low Striatal Dopamine and Iron Accumulation
    Neuropsychopharmacology ·Cohort Study · April 28, 2026

    Schizophrenia Subtype Shows Low Striatal Dopamine and Iron Accumulation

    A frontotemporal dementia-like phenotype in schizophrenia patients challenges the universal hyperdopaminergic model of the disease.

  16. Symptom-Based Dosing Reduces Discharge Time in Neonatal Opioid Withdrawal
    JAMA ·Randomized Controlled Trial · April 28, 2026

    Symptom-Based Dosing Reduces Discharge Time in Neonatal Opioid Withdrawal

    A cluster randomized trial shows symptom-based dosing shortens medical readiness for discharge when paired with the Eat, Sleep, Console model.

  17. Robotic CT-Guided Cannula Placement Shows Sub-Millimeter Precision in Phantom Models
    Journal of neurosurgery ·In Vitro Study · April 28, 2026

    Robotic CT-Guided Cannula Placement Shows Sub-Millimeter Precision in Phantom Models

    Researchers placed multiple convection-enhanced delivery cannulas in under 30 minutes with high stereotactic accuracy.

  18. Hemothorax Volume Under 300 mL Predicts Successful Observation
    Journal of Trauma: Injury, Infection, and Critical Care ·Cohort Study · April 28, 2026

    Hemothorax Volume Under 300 mL Predicts Successful Observation

    A multicenter study finds that traumatic hemothorax volume over 300 mL increases the risk of observation failure sixteenfold.

  19. Brain-Responsive Neurostimulation Reduces Focal Seizures by 82% at Three Years
    Neurology ·Registry Study · April 28, 2026

    Brain-Responsive Neurostimulation Reduces Focal Seizures by 82% at Three Years

    A prospective real-world study shows higher seizure reduction rates and lower SUDEP risk than observed in initial clinical trials.

  20. Resuscitative Thoracotomy Yields 7.4 Percent Survival in Combat Trauma
    Journal of Trauma: Injury, Infection, and Critical Care ·Cohort Study · April 28, 2026

    Resuscitative Thoracotomy Yields 7.4 Percent Survival in Combat Trauma

    A retrospective cohort study shows survival rates comparable to civilian trauma despite high-energy blast injuries and severe hemorrhage.

  21. Auricular Vagus Nerve Stimulation Manages Refractory Sympathetic Hyperactivity Post-Hemorrhage
    Frontiers in Neuroscience ·Case Report · April 28, 2026

    Auricular Vagus Nerve Stimulation Manages Refractory Sympathetic Hyperactivity Post-Hemorrhage

    Adjunctive neuromodulation improved tachypnea and consciousness while reducing polypharmacy in a patient with intracerebral hemorrhage.

  22. Epilepsy and Disability Status Increase Resource Use After Total Hip Arthroplasty
    Journal of Arthroplasty ·Cohort Study · April 28, 2026

    Epilepsy and Disability Status Increase Resource Use After Total Hip Arthroplasty

    A study of 32,459 younger Medicare beneficiaries shows a 10.7% readmission rate, with epilepsy driving higher healthcare utilization.

  23. PHQ-9 Scores Conflate Symptom Frequency and Subjective Burden
    Journal of Affective Disorders ·Cohort Study · April 28, 2026

    PHQ-9 Scores Conflate Symptom Frequency and Subjective Burden

    Longitudinal data shows the depression screening tool captures a general severity signal but lacks precision in distinguishing distress.

  24. Epilepsy Patients Show Amyloid-Independent Tau Deposition Linked to Clinical Severity
    Brain ·Cohort Study · April 27, 2026

    Epilepsy Patients Show Amyloid-Independent Tau Deposition Linked to Clinical Severity

    PET imaging and proteomics reveal that chronic epilepsy correlates with widespread tau accumulation and accelerated multi-organ aging.